Your browser doesn't support javascript.
loading
Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis.
Zhou, Jun; Sun, Yongkun; Zhang, Wen; Yuan, Jiajia; Peng, Zhi; Wang, Wei; Gong, Jifang; Yang, Lin; Cao, Yanshuo; Zhao, Hong; Chen, Chao; Wang, Weifeng; Shen, Lin; Zhou, Aiping.
Afiliação
  • Zhou J; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
  • Sun Y; Department of Medical Oncology , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
  • Zhang W; Hebei Cancer Hospital , Chinese Academy of Medical Sciences , Langfang , China.
  • Yuan J; Department of Medical Oncology , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
  • Peng Z; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
  • Wang W; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
  • Gong J; Department of Medical Oncology , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
  • Yang L; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
  • Cao Y; Department of Medical Oncology , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
  • Zhao H; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
  • Chen C; Department of Hepatobiliary Surgery , National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.
  • Wang W; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. , Nanjing , China.
  • Shen L; OrigiMed , Shanghai , China.
  • Zhou A; Department of Gastrointestinal Oncology , Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) , Peking University Cancer Hospital and Institute , Beijing , China.
Hepatology ; 77(1): 65-76, 2023 01 01.
Article em En | MEDLINE | ID: mdl-35491432
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Proteínas Proto-Oncogênicas p21(ras) Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China